Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Implanet Announces a Commercial, Technological and Financial Partnership With Sanyou Medical, a Chinese Manufacturer of Medical Devices for Spine Surgery
IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company […]
Regard Raises $15.3 Million Series A to Accurately and Quickly Uncover Patient Diagnoses
Regard (formerly known as HealthTensor), a software company developing an artificial intelligence (AI) co-pilot for physicians […]
3Spine, Inc. Completes First US Surgeries
3Spine, Inc., a medical device company developing total joint replacement for the lumbar spine, today […]
H.E.L Group Releases iso-BTC+ Calorimeter for Isothermal Battery Performance Testing
H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, […]
Bio-Rad Introduces CFX Opus Deepwell Real-Time PCR Detection System
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and […]
Englewood Health Introduces Robot-Assisted Spine Surgery with GPS-like Precision to New Jersey
Englewood Health has become the first hospital in New Jersey and one of only 20 hospitals in […]
Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma
Antengene Corporation Limited (“Antengene“ SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, […]
GSK Presents Promising New Data for Bepirovirsen, an Investigational Treatment for Chronic Hepatitis B
GSK plc today announced promising interim results from the B-Clear phase IIb trial showing that […]
Moderna Announces Bivalent Booster mRNA -1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants Ba.4 and Ba.5
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Huma Joins Forces With Independent Healthcare Provider to Launch Virtual Ward Service for the NHS
Huma are partnering with Xyla Elective Care, a national provider of NHS England-funded elective services, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more